BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 7441521)

  • 41. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat.
    Tuchweber B; Desmoulière A; Bochaton-Piallat ML; Rubbia-Brandt L; Gabbiani G
    Lab Invest; 1996 Jan; 74(1):265-78. PubMed ID: 8569191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A minimally toxic dose of methylene dianiline injures biliary epithelial cells in rats.
    Kanz MF; Gunasena GH; Kaphalia L; Hammond DK; Syed YA
    Toxicol Appl Pharmacol; 1998 Jun; 150(2):414-26. PubMed ID: 9653073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose-dependent pharmacokinetics of methotrexate and 7-hydroxymethotrexate in the rat in vivo.
    Bremnes RM; Slørdal L; Wist E; Aarbakke J
    Cancer Res; 1989 Nov; 49(22):6359-64. PubMed ID: 2804982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of bile duct ligation, bile duct cannulation, and hypothermia on alpha-naphthylisothiocyanate-induced hyperbilirubinemia and cholestasis in rats.
    Roberts RJ; Plaa GL
    Gastroenterology; 1966 Jun; 50(6):768-74. PubMed ID: 5212377
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of inositol 1,4,5-trisphosphate receptors from bile duct epithelia is a common event in cholestasis.
    Shibao K; Hirata K; Robert ME; Nathanson MH
    Gastroenterology; 2003 Oct; 125(4):1175-87. PubMed ID: 14517800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics and pharmacodynamics of gallamine triethiodide in patients with total biliary obstruction.
    Ramzan IM; Shanks CA; Triggs EJ
    Anesth Analg; 1981 May; 60(5):289-96. PubMed ID: 7194593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative temporal analysis of 99mTechnetium p-isopropyl-iminodiacetic acid (PIPIDA) as a measure of hepatic function in health and disease.
    Joshi SN; George EA; Perrillo RP
    Gastroenterology; 1981 Dec; 81(6):1045-51. PubMed ID: 7286582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatic proline after bile duct ligation in rats.
    Chen TS; Boesch CL; Leevy CM
    Experientia; 1983 Jun; 39(6):585-6. PubMed ID: 6852191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kinetics of meperidine N-demethylation in the perfused rat liver preparation.
    Babiak LM; Cherry WF; Fayz S; Pang KS
    Drug Metab Dispos; 1984; 12(6):698-704. PubMed ID: 6150818
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Similarities and differences between models of extrahepatic biliary obstruction and complete biliary retention without obstruction in the rat.
    Hardison WG; Weiner RG; Hatoff DE; Miyai K
    Hepatology; 1983; 3(3):383-90. PubMed ID: 6840684
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of post-surgical alterations in the bile duct-cannulated rat.
    Bachir-Cherif D; Blum D; Braendli-Baiocco A; Chaput E; Pacheco GC; Flint N; Haiker M; Hoflack JC; Justies N; Neff R; Starke V; Steiner G; Tournillac CA; Singer T; Ubeaud-Séquier G; Schuler F
    Xenobiotica; 2011 Aug; 41(8):701-11. PubMed ID: 21521079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of lidocaine and its major metabolite- monoethylglycinexylidide (MEGX) in rabbits with experimental common bile duct obstruction.
    Wójcicki J; Sulikowski T; Wójcicki M; Droździk M; Gawrońska-Szklarz B; Barcew-Wiszniewska B; Skowron J; Rózewicka L; Gołdyn U
    Eur J Drug Metab Pharmacokinet; 1995; 20(2):119-23. PubMed ID: 8582436
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alterations of nucleolar organizer regions of smooth muscle cells in bile duct following biliary ligation in rat.
    Shih RH; Ker CG
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 Dec; 10(12):658-64. PubMed ID: 7853425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alpha-interferon prevents liver collagen deposition and damage induced by prolonged bile duct obstruction in the rat.
    Muriel P
    J Hepatol; 1996 May; 24(5):614-21. PubMed ID: 8773918
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms responsible for the altered pharmacokinetics of bosentan: analysis utilizing rats with bile duct ligation-induced liver dysfunction.
    Horiuchi I; Mori YI; Taguchi M; Ichida F; Miyawaki T; Hashimoto Y
    Biopharm Drug Dispos; 2009 Sep; 30(6):326-33. PubMed ID: 19639656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stereological and functional analysis of liver mitochondria from rats with secondary biliary cirrhosis: impaired mitochondrial metabolism and increased mitochondrial content per hepatocyte.
    Krähenbühl S; Krähenbühl-Glauser S; Stucki J; Gehr P; Reichen J
    Hepatology; 1992 Jun; 15(6):1167-72. PubMed ID: 1592355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of glucagon control of gluconeogenesis in liver cells from rats with bile duct obstruction.
    Schölmerich J; Becher MS; Baumgartner U; Gerok W
    Biochem Biophys Res Commun; 1985 Feb; 126(3):1146-53. PubMed ID: 3977908
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pentobarbital pharmacokinetics in the normal and in the hepatectomized rat.
    Ossenberg FW; Peignoux M; Bourdiau D; Benhamou JP
    J Pharmacol Exp Ther; 1975 Jul; 194(1):111-6. PubMed ID: 1151743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The isolation and characterization of a bile ductule cell population from normal and bile-duct ligated rat livers.
    Grant AG; Billing BH
    Br J Exp Pathol; 1977 Jun; 58(3):301-10. PubMed ID: 326290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of intragastrically administered digoxin in rabbits with experimental bile duct obstruction.
    Wójcicki M; Drozdzik M; Sulikowski T; Gawronska-Szklarz B; Wójcicki J; Rózewicka L; Skowron J; Zielinski S; Musial HD; Zakrzewski J
    J Pharm Pharmacol; 1997 Nov; 49(11):1082-5. PubMed ID: 9401942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.